Vaccine: Timeline of key events

Mouseover the event title for a more detailed description of the event (if available). To search for particular terms in the description of the event enter the term in the box below 'Event' on the table and press 'enter'. Alternatively use the dropdown lists to filter by Person, Place or Science. Click here to clear the filter.

The vaccine was originally developed by researchers at Scripps Research Institute to stimulate immune system to produce broadly neutralising antibodies against HIV variants. The trial is funded by by the International AIDS Vaccine Initiative.2022-05-19T00:00:00+0000The vaccine, created by Pfizer, was designed to encode World Health Organization recommended strains for the Northern Hemisphere 2022-23 cell culture - or recombinant-based influenza vaccines. 2022-09-14T00:00:00+0000
Date Event People Places Sciences
19 May 2022Phase I trial launched with mRNA vaccine against HIV in Africa Scripps Research Institute, ModernamRNA, vaccines
14 Sep 2022First phase 3 efficacy trial launched with mRNA-based influenza vaccine PfizermRNA, vaccines

19 May 2022

Phase I trial launched with mRNA vaccine against HIV in Africa

14 Sep 2022

First phase 3 efficacy trial launched with mRNA-based influenza vaccine

Respond to or comment on this page on our feeds on Facebook, Instagram or Twitter.